The immunological relationship between liver flukes and their mammalia
n hosts is being unravelled by in vivo and in vitro studies, Vaccine s
tudies in cattle and sheep with purified antigens (fatty acid binding
protein, FABP; glutathione S-transferase, GST; cathepsin L, CatL; hemo
globin) have shown that high reductions in worm burdens (31-72%) and e
gg production (69-98%) can be achieved, raising the realistic possibil
ity that immunological control of Fasciola infection is a commercially
achievable goal, Combination vaccines may also be feasible since a co
cktail of CatL and hemoglobin elicits a significant 72% protection in
cattle. Analysis of immune responses to Fasciola during infection in r
uminants suggests that chronic infection correlates with a type 2 help
er T cell response, implying that type 1 helper T cell responses are d
own-regulated in fasciolosis. Recent results studying the resistance o
f Indonesian Thin Tail (ITT) sheep to F. gigantica have shown that thi
s breed exhibits high innate (or rapidly acquired) resistance to infec
tion and acquires a higher level of resistance after a primary challen
ge. Initial studies suggest that the resistance of ITT sheep to F. gig
antica may be determined by a major gene. Merino sheep also acquire re
sistance to F. gigantica. In contrast, ITT and Merino sheep do not exh
ibit resistance to F. hepatica. These results suggest that there are f
undamental differences between these two species of Fasciola in the bi
ology of their interaction with the sheep immune system, Irt vitro stu
dies on immune mechanisms of killing of juvenile fluke have shown that
juvenile larvae of F. hepatica are susceptible to antibody-dependent
killing by activated rat macrophages in vitro which is mediated by nit
ric oxide. Future studies on the immune effector mechanisms expressed
by resistant sheep which control infection by F. gigantica will lead t
o new knowledge which may allow the design of more effective vaccines
for fasciolosis. (C) 1997 Australian Society for Parasitology. Publish
ed by Elsevier Science Ltd.